Technology | Oncology Information Management Systems (OIMS) | July 13, 2018

RaySearch Releases New Version of RayCare OIS

Version 2A features new task- and rule-based scheduling for all clinic resources, clinical document and form management connected to task management

RaySearch Releases New Version of RayCare OIS

July 13, 2018 — RaySearch has released RayCare 2A, the latest version of its flagship oncology information system (OIS). RayCare is designed to support the workflow in a modern oncology center, connecting the different oncology disciplines, boosting efficiency and ensuring optimal use of resources.

RayCare is developing rapidly with clinical input from leading cancer centers worldwide. The first clinical version of RayCare was released in December 2017, and Iridium Cancer Network in Belgium started using it clinically after only two months. RayCare 2A introduces new features and a range of general system enhancements.

New features include:

  • Task-based and rule-based scheduling for all clinic resources;
  • Management of clinical documents and forms connected to task management; and
  • Additional treatment management functions.

RayCare’s advanced workflow capabilities have been further enhanced to enable customization of the individual patient's workflow, as well as automatic capture and management of billable codes from tasks performed in the workflow.

RayCare 2A also incorporates RayPACS, a managed picture archiving and communication system that makes it fast and easy to retrieve and share images. RayPACS is fully integrated with the RayCare workflow management system, enabling automated imaging workflows. All DICOM and non-DICOM objects relevant for radiation oncology can be stored, and rules for DICOM routing can be set up easily based on any DICOM tag.

For more information: www.raysearchlabs.com

Related Content

Non-oncology doctors’ knowledge of oncology is frequently not up to date, with risks in the communication with patients  

Getty Images

News | Radiation Oncology | September 20, 2021
September 20, 2021 — The rapid pace of developments in the oncology field, mainly brought by cancer immunotherapy, me
IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, and SCK CEN (Belgian Nuclear Research Center) announced a strategic R&D partnership to enable the production of Actinimum-225 (225Ac), a novel radioisotope which has significant potential in the treatment of cancer.
News | Radiation Oncology | September 17, 2021
September 17, 2021 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, a
Evaluation of therapeutic efficacy of drug candidates in preclinical oncology with positron emission tomography (PET)

Getty Images

Feature | PET Imaging | September 14, 2021 | By Todd Sasser, Ph.D.
With a wealth of landmark studies in Breast, Cervical, Melanoma, Prostate, Colorectal, Oesophagus, Endocrine and Lung cancer, the ESMO Congress 2021 is a clear demonstration that oncology research has once again gathered momentum after being temporarily stopped in its tracks by the outbreak of the virus

Getty Images

News | Radiation Oncology | September 13, 2021
September 13, 2021 — At the opening press conference of the ...
Comment letters on the 2022 physician fee schedule and Radiation Oncology Model urge CMS to scale back extreme cuts that jeopardize access to life-saving cancer treatments

Getty Images

News | ASTRO | September 09, 2021
September 9, 2021 — The American Society for Radiation Oncology (AS...
At the recent 2021 AAPM Meeting in July, Sun Nuclear Corporation featured its comprehensive portfolio of independent, integrated quality management solutions for radiation therapy and diagnostic imaging.
News | Quality Assurance (QA) | September 02, 2021
September 2, 2021 — At the recent 2021 AAPM Meeting
Cedars-Sinai Cancer researchers have discovered that intestinal microorganisms help regulate anti-tumor immune responses to radiation treatments.

Getty Images

News | Radiation Therapy | September 01, 2021
September 1, 2021 — The study, published on Aug.